Keyphrases
Next-generation Sequencing
100%
Diagnostic Ability
100%
Anaplastic Large Cell Lymphoma
100%
Anaplastic Lymphoma Kinase
100%
Fusion Analysis
100%
TNF Receptor-associated Factor 1
100%
Fusion Partner
16%
Anaplastic Lymphoma Kinase-positive
16%
Nucleophosmin 1 (NPM1)
16%
Immunostaining
8%
Clinical Significance
8%
Lymph Node
8%
Clinical Course
8%
Conventional Chemotherapy
8%
Fusion Assay
8%
Non-Hodgkin Lymphoma
8%
Granzyme B
8%
Young Males
8%
Exon 7
8%
Worse Prognosis
8%
Formalin-fixed Paraffin-embedded Tissue
8%
Neoplastic Cells
8%
RNA-based
8%
Lymphoma Patients
8%
Tissue Diagnosis
8%
CD30
8%
Atypical Cells
8%
Histologic Evaluation
8%
Favorable Prognosis
8%
Horseshoe Kidney
8%
Excisional Biopsy
8%
Cervical Lymphadenopathy
8%
RNA Analysis
8%
Rare Translocations
8%
Exon 20
8%
ALK Inhibitor
8%
Gene-specific Primers
8%
TIA1
8%
Anaplastic Lymphoma Kinase Rearrangement
8%
T-cell Neoplasm
8%
Anchored multiplex PCR
8%
Biochemistry, Genetics and Molecular Biology
TNF Receptor Associated Factor
100%
Next Generation Sequencing
100%
Anaplastic Lymphoma Kinase
100%
Fibrinogen
100%
RNA
18%
Exon
12%
NPM1
12%
Immunostaining
6%
Multiplex Polymerase Chain Reaction
6%
CD30
6%
T Cell
6%
CD4
6%
CD2
6%
Granzyme B
6%